Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer

Clinical trial NCT06363708 · UNKNOWN

Trial details

NCT number: NCT06363708
Sponsor: Zhongnan Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Endometrial Neoplasms

Start date: 2024-06-01
Primary completion: 2025-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.